151 related articles for article (PubMed ID: 38246417)
1. Amiodarone-induced thyrotoxicosis: Should surgery be considered?
Frey S; Caillard C; Mahot P; Drui D; Mirallié E
Ann Endocrinol (Paris); 2024 Apr; 85(2):136-141. PubMed ID: 38246417
[TBL] [Abstract][Full Text] [Related]
2. Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis.
Cappellani D; Papini P; Pingitore A; Tomisti L; Mantuano M; Di Certo AM; Manetti L; Marconcini G; Scattina I; Urbani C; Morganti R; Marcocci C; Materazzi G; Iervasi G; Martino E; Bartalena L; Bogazzi F
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31545358
[TBL] [Abstract][Full Text] [Related]
3. Mortality After Total Thyroidectomy for Amiodarone-Induced Thyrotoxicosis According to Left Ventricular Ejection Fraction.
Frey S; Caillard C; Mahot P; Pattier S; Volteau C; Knipping G; Lande G; Drui D; Mirallié E
Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1542-1549. PubMed ID: 37317630
[TBL] [Abstract][Full Text] [Related]
4. Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy.
Cappellani D; Papini P; Di Certo AM; Morganti R; Urbani C; Manetti L; Tanda ML; Cosentino G; Marconcini G; Materazzi G; Martino E; Bartalena L; Bogazzi F
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32678873
[TBL] [Abstract][Full Text] [Related]
5. [Subtotal thyroidectomy. A treatment to keep in mind in amiodarone-induced thyrotoxicosis].
López Mínguez JR; Díaz Pérez de Madrid J; García Andoaín JM; García Guerrero JJ; Morales Pérez F; Alvarez Suárez-Bárcenas JM; Altozano Gómez JC; Redondo Méndez A; Alonso Ruiz F
Rev Esp Cardiol; 1996 Jun; 49(6):474-6. PubMed ID: 8753914
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone-Induced Thyrotoxicosis - Literature Review & Clinical Update.
Souza LVF; Campagnolo MT; Martins LCB; Scanavacca MI
Arq Bras Cardiol; 2021 Nov; 117(5):1038-1044. PubMed ID: 34817015
[TBL] [Abstract][Full Text] [Related]
7. An audit of amiodarone-induced thyrotoxicosis--do anti-thyroid drugs alone provide adequate treatment?
Patel N; Inder WJ; Sullivan C; Kaye G
Heart Lung Circ; 2014 Jun; 23(6):549-54. PubMed ID: 24613043
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone and the thyroid.
Jabrocka-Hybel A; Bednarczuk T; Bartalena L; Pach D; Ruchała M; Kamiński G; Kostecka-Matyja M; Hubalewska-Dydejczyk A
Endokrynol Pol; 2015; 66(2):176-86. PubMed ID: 25931048
[TBL] [Abstract][Full Text] [Related]
9. Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy.
Claxton S; Sinha SN; Donovan S; Greenaway TM; Hoffman L; Loughhead M; Burgess JR
Aust N Z J Surg; 2000 Mar; 70(3):174-8. PubMed ID: 10765898
[TBL] [Abstract][Full Text] [Related]
10. [Effect of amiodarone on the thyroid function and safety of the therapy--what's new].
Hen K; Czarnywojtek A; Stangierski A; Warmuz-Stangierska I; Zdanowska J; Florek E; Ruchała M
Przegl Lek; 2012; 69(10):1135-9. PubMed ID: 23421109
[TBL] [Abstract][Full Text] [Related]
11. Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.
Bogazzi F; Aghini-Lombardi F; Cosci C; Lupi I; Santini F; Tanda ML; Miccoli P; Basolo F; Pinchera A; Bartalena L; Braverman LE; Martino E
J Endocrinol Invest; 2002 Feb; 25(2):176-80. PubMed ID: 11929091
[TBL] [Abstract][Full Text] [Related]
12. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
[TBL] [Abstract][Full Text] [Related]
13. Approach to the patient with amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone-induced thyroid dysfunction.
Danzi S; Klein I
J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
Gerber H; Noth D
Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
[TBL] [Abstract][Full Text] [Related]
16. Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis.
Cappellani D; Bartalena L; Bogazzi F
J Endocrinol Invest; 2024 Feb; 47(2):275-283. PubMed ID: 37731073
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone-induced thyrotoxicosis. A review.
Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
[TBL] [Abstract][Full Text] [Related]
19. Total thyroidectomy in amiodarone-induced thyrotoxicosis. Preoperative, intraoperative and postoperative considerations.
Batori M; Nardi M; Chatelou E; Straniero A; Makrypodi M; Ruggieri M
Eur Rev Med Pharmacol Sci; 2006; 10(4):187-90. PubMed ID: 16910349
[TBL] [Abstract][Full Text] [Related]
20. Monitoring thyroid function during amiodarone use.
Sharma P; Sheikh R; Siribaddana N; Sathyanarayanan A; Fernando D; Muraleedharan V
Br J Hosp Med (Lond); 2024 Jan; 85(1):1-5. PubMed ID: 38300678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
